Weight-loss drugs drive record pharma revenues, reshaping market

Pharmaceutical companies report surging revenues from weight-loss drugs, now a top growth segment. The trend signals sustained demand and potential market expansion, though competitive dynamics and pricing pressures remain uncertain. This development underscores a structural shift in pharma earnings, with implications for sector valuations and healthcare spending.